Lineus Medical Signs Partnership Agreement with DIMA MedTech to Support Expansion into Italy
The Floridant/10343413

FAYETTEVILLE, Ark. - Floridant -- Lineus Medical is pleased to announce a new distribution agreement with DIMA MedTech, marking the company's entry into the Italian market and further expanding its growing presence across Europe after receiving CE mark in December of 2025. Through this agreement, DIMA MedTech will provide Lineus Medical with a local presence in Italy as well as support the introduction and expansion of SafeBreak Vascular throughout Italy.

SafeBreak Vascular is the only breakaway device for IV lines clinically proven to reduce multiple IV complications.¹ When a harmful force is placed on an IV line, SafeBreak intentionally separates to remove the damaging force from the IV line and protect the patient's vascular access. Upon separation, valves on both ends of the device close, preventing medicine spills from the pump and blood loss from the patient. The separated device causes the IV pump to alarm, notifying the nursing staff to check on the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile device is installed, and the patient's infusion is continued. SafeBreak Vascular is cleared for all vascular lines down to two weeks of age– delivering better outcomes for patients, efficiency for nurses, and cost savings for hospitals alike.¹

More on The Floridant

• Airplane Repo" Star Ken Cage And Cloud Yachts Join Forces On Distressed Yachts And Aircraft
• GreenPointe Holdings promotes Megan Maldonado to Senior Developed Real Estate Manager
• Don't Miss the Marine Event of the Season — Spaces Going Quickl
• Defense & Space Strategy Strengthens as New Leadership Builds on NASA Results and Expanding Multi-Orbit Opportunities for Ascent Solar Technologies
• Venice FF 2026, Samantha Casella screens The Serpent's Caress

Larry Hayes, Lineus Medical's Chief Commercial Officer, stated, "This agreement marks another significant milestone in Lineus Medical's international growth. By partnering with DIMA MedTech, we are beginning our commercialization strategy in Europe and continuing to build momentum for broader global adoption. DIMA MedTech's local expertise and established network make them the right partner to drive commercial success throughout Italy."

Vance Clement, CEO of Lineus Medical, stated, "Expanding into Italy is a meaningful step forward in our mission to remove the "pains" associated with medical lines. First came European regulatory clearance for our product, and next is the establishment of a robust European distribution network. DIMA MedTech is a terrific distributor in Italy and our first in Europe."

About Lineus Medical

Lineus Medical develops innovative medical technologies designed to improve patient safety and healthcare efficiency. Its flagship product, SafeBreak Vascular, is a breakaway device for IV lines that helps protect patients from accidental IV dislodgements and associated complications.¹

More on The Floridant

• 8th Edition of Filming Italy Venice Awards Cinema Talent 
• STS Capital Partners is pleased to announce the appointment of Barry Brown as Vice President, Business Development
• BankAtlas Launches U.S. Banking Risk Quarterly; Finds Q2 Improvement Uneven Across U.S. Banks
• Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice
• Beucher Insurance Agency Becomes Diamond Sponsor of Mt. Dora Christian Academy

About DIMA MedTech

DIMA MedTech is an operational partner for international medical technology companies seeking to establish and grow their presence in Italy. The company provides regulatory support, nationwide distribution, technical assistance, and local market expertise through a flexible operational model designed to simplify healthcare market entry and expansion.

References:

1. Data on File.